Zobrazeno 1 - 10
of 2 936
pro vyhledávání: '"G, GASBARRINI"'
Publikováno v:
Microbiota in Health and Disease, Vol 3 (2021)
Objectives: Rifaximin seems to be effective and safe in treating small intestinal bacterial overgrowth (SIBO), however, to date there is no consensus regarding the proper timing of therapy. The present study aims to provide preliminary data regarding
Externí odkaz:
https://doaj.org/article/4a2b6d5cb4d441b6a6b759e5d1f7c021
Publikováno v:
Microbiota in Health and Disease, Vol 3 (2021)
Externí odkaz:
https://doaj.org/article/1a4d050bd51842ac992f5e0ab5537e7a
Autor:
G. Gasbarrini, C. Mosoni
Publikováno v:
Microbiota in Health and Disease, Vol 1 (2019)
The ingestion of germs which take part in the constitution of the intestinal flora is well documented in human history; in fact, as shown in several cave paintings, since the Neolithic Age, the changes in human habits to a lifestyle based on farming
Externí odkaz:
https://doaj.org/article/eea9be8fd8a54a0c8f5a653303543783
Publikováno v:
Digestive and Liver Disease. 55:S98-S99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9d4c7163ad25cb4c5e0aa4c350c13e4
https://doi.org/10.1016/s1590-8658(23)00271-2
https://doi.org/10.1016/s1590-8658(23)00271-2
Autor:
G, Gasbarrini, T, Dionisi, G R, Corazza, N, Aronico, G, Cammarota, G, Ianiro, I, De Vitis, M, Candelli, F A, Mancarella, S, Simeoni, G, Addolorato, F, Bonvicini
Publikováno v:
European review for medical and pharmacological sciences. 25(12)
Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3779a9c6ede2b4eda340252afc889fc7
https://pubmed.ncbi.nlm.nih.gov/34227075
https://pubmed.ncbi.nlm.nih.gov/34227075
Publikováno v:
European review for medical and pharmacological sciences. 24(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01f33384e4ca522d56f6994f2c8eacdf
https://pubmed.ncbi.nlm.nih.gov/32432790
https://pubmed.ncbi.nlm.nih.gov/32432790
Clostridioides difficile (formerly Clostridium difficile) infection (CDI) represents a worrisome condition, often underestimated, with severe clinical presentations, frequently requiring intensive care unit (ICU) admission. The aim of the present exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::4b2fe34c007ddcfe9ff8bcce79599d35
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121386
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121386
Autor:
G, Gasbarrini, F, Bonvicini
Publikováno v:
European review for medical and pharmacological sciences. 22(16)
Helicobacter pylori (Hp) is a pathogen which causes gastric diseases from gastritis to ulcer, cancer, and MALT Lymphoma. The higher grade of virulence belongs to strains harbouring CagA oncoprotein. Hp cag Pathogenicity Island encoded Type IV Secreti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e575dd661378a002c790ca27e364a13
https://pubmed.ncbi.nlm.nih.gov/30178856
https://pubmed.ncbi.nlm.nih.gov/30178856
Autor:
B. Funaro, Andrea Lupascu, M.E. Ainora, G. Gasbarrini, Brigida E. Annicchiarico, M. Siciliano, Paolo Tondi, Alessandro Gasbarrini, Maurizio Pompili, Laura Riccardi, F.R. Ponziani, Maria Assunta Zocco, M. Garcovich, A. Quadarella
Publikováno v:
Digestive and Liver Disease. 50:e219-e220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8e497c5d45ffe1cb911ed47f203980b
https://doi.org/10.1016/s1590-8658(18)30615-7
https://doi.org/10.1016/s1590-8658(18)30615-7